GLP-1 Oracle
Providers Coverage Costs Reference
Dose calculator

51/51 states verified · 24/25 providers audited

Cost

Zepbound and Wegovy: what each costs, and what your plan is likely to do

Wegovy is the cheaper cash price at every published tier. Novo Nordisk sells Wegovy through NovoCare at $199 a month for the two starting doses if you are new to it, stepping up to $349 a month after the first two fills from 31 December 2026, and the Wegovy pill is $149 a month at 1.5 mg.

What that is based on

Eli Lilly sells Zepbound through LillyDirect at $299 for the 2.5 mg starting dose, which Lilly states is not approved as a maintenance dose, and $399 to $699 at the doses people stay on. Lilly’s purchase offer brings 7.5 mg and above to $449 a month, and it holds only while every refill lands within 45 days of the last one. Coverage is closer than the price. Across the 51 US Medicaid jurisdictions this site has read, semaglutide is covered subject to prior authorization in 13 and refused in 12; tirzepatide is covered subject to prior authorization in 11 and refused in 11. Both are approved for chronic weight management, and each also carries an indication the other does not: Wegovy for cardiovascular risk reduction, Zepbound for obstructive sleep apnea.

By John Weeks Updated September 4, 2026

Cash price, per month, from the manufacturer

Wegovy
$199 Starting doses, new patients. $349 after two fills from 31 December 2026
Zepbound
$399 Maintenance runs $399 to $699, or $449 at 7.5 mg and above while every refill is on time. $299 is the starting dose only

Wegovy is cheaper at every published tier, and the gap narrows once Lilly’s purchase offer applies: $449 against $349. What neither figure tells you is which one a prescriber will put you on, or which your plan will fund, and this page does not answer either.

Cash price · per month

$149 to $699

The Wegovy pill at the low end, Zepbound at 10 mg and above at the high end. Both are cash prices from the manufacturer.

The short version

Wegovy, cash, starting doses
$199 a month if you are new to it
Zepbound, cash, maintenance
$399 to $699 a month, or $449 at 7.5 mg and above on Lilly’s purchase offer if every refill lands within 45 days
State Medicaid, semaglutide
Covered with prior authorization in 13 of 51 jurisdictions, refused in 12, diabetes-only in 22
State Medicaid, tirzepatide
Covered with prior authorization in 11 of 51, refused in 11, diabetes-only in 22
Approved for, beyond weight management
Wegovy adds cardiovascular risk reduction. Zepbound adds obstructive sleep apnea
What this page does not tell you
Which one is more effective, and which one to ask a prescriber about. Both are matters for a prescriber and the label, and nothing on this site answers either

We earn a referral fee from some of these providers. It never changes what you pay. How we make money

Providers offering this medication

More on Tirzepatide

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

  1. 1
    Zepbound savings and self-pay pricing

    Eli Lilly and Company Primary text read and checked Checked August 25, 2026

  2. 2
    Wegovy cost, coverage and savings

    Novo Nordisk (NovoCare) Primary text read and checked Checked September 3, 2026